INTRODUCTION
Drugs such as estrogens, anabolic steroids, pheinothliazines, and others (1) may cause intralhepatic cholestasis by interfering with either bile salt dlependenit, iildepen(dent, or both componenits ofbile flow. The causes(s) of bile secretorv failure (cholestasis) is unknown, but these agents have focused attentioIn oIn abnormalities in the hepatocyte. Ethinyl estradiol, a synthetic estrogen, has been extensively studiedl as a dcrug whiclh produces bile secretory failure characterized by (lecreases in the bile salt independent component of bile flow (2) (3) (4) , the maximumti capacity to excrete organic anions such as bile acids (5) , bilirubin (6) , and bromosulfophthalein (4, 7) and decreased hepatic Na+-K+-ATPase activity (8, 9) . It has been suggested that this diffuse abnormality in biliary secretory processes is primarily the result of changes in membrane lipid structure (9) .
In these studies, we have sought to determiiine whether the reduction of bile acid transport in ethinyl estradiol-treated rats is also related to changes in mlleml[-brane lipids; or rather is caused by alterations of bile salt receptors, or decreased driving forces for the sodium transport system secondary to reduced Na+-K+-ATPase activity. The results indicate that alterations in liver surface membrane lipid composition may be responsible for decreased bile acid transport in ethinyl estradiol-treated rats.
METHODS
Materials atnd animilals. Male Sprague-Dawley rats veighing 180-250 g (Charles River Breeding Laboratories, Inic., Wilmington, Mass.) allowed free access to Purina Rat Chow (Ralston Purina Co., St. Louis, Mo.) and water were used in all experiments. Rats were kept in cages vith aspen wood chip bedding (American Excelsior Co., Denver, Colo.) and alternating 12 h of light and darkness. Insecticides were not used in the animal quarters.
[24-'4C]cholic acid (50-60 mCi/mmol, 99% radiochemically pure) from New England Nuclear (Boston, Mass.) and ['4C ]leucine (348 mCi/mmole from Amersham Corp., Arlington Heights, Ill.) were used. Taurocholic acid (>95% purity) was obtained from Maybridge Research Chemicals, Cornwall, England. Purity of bile acids was confirmed by thin-layer chromatography (10) . Adenosine 5-triphosphate, adenosine 5'-monophosphate, ouabain, albumin (bovine), EGTA, and ethinyl estradiol were obtained from Sigma Chemical Co., St. Louis, Mo. Triton WR-1339 (oxyethylated tertiary octylphenol polymethylene polymer) was obtained from Ruger Chemical Company, Inc. (Irvington, N. J.).
Ethinyl estradiol was dissolved in corn oil and administered through a gastric tube, 5 mg/kg body wt daily for 5 d, or given subcutaneously in either 0.5 ml ofcorn oil or 0.2 ml propylene glycol. Control rats received either 0.5 ml of corn oil or 0.2 ml propylene glycol. Control and randomly selected ethinyl estradiol-treated rats were fasted overnight and injected on the fifth day of treatment with Triton WR-1339 (62.5 mg/ml dissolved in 0.9% saline so that each received 22.5 mg/100 g body wt i.p.) and killed 16 h later. In some experiments cycloheximide 15 mg/ml was dissolved in 0.9% saline and injected intraperitoneally at a dosage of 150 ,Ag/100 g body wt, 30 min before the administration of Triton WR-1339. In an additional set ofexperiments phenobarbital (80 mg/kg body wt i.p.) was administered daily either alone or simultaneously with ethinyl estradiol for 5 d.
Liver surface membrane fractions were prepared through the final stage according to the procedure of Neville (11) . Surface membrane fractions were washed once each with icecold 1 mM NaHCO3 and 0.15 M NaCl. Microsomal fractions were prepared from the supernate by modification of the procedure of Evans and Gurd (12) as previously described (13) . Microsomal fractions were washed by the method of Weihing et al. (14) to remove adsorbed and intracisternal proteins.
Enzyme and chemical assays. Na+-K+-ATPase (ATP phosphohydrolase, EC 3.6.1.3) was assayed in liver surface membrane fractions and in liver homogenates according to the method of Ismail-Beigi and Edelman (15) , after overnight freezing (16) . 5'-nucleotidase activity (EC 3.1.3.5) was measured by the method of Song and Bodansky (17) , glucose-6-phosphatase (EC 3.1.3.9) activity according to deDuve et al. (18) , alkaline phosphomonoesterase (EC 3.1.3.1) using ,Bglycerol phosphate as substrate according to Bodansky (19) , and acid phosphomonoesterase (EC 3.1.3.2) according to Shibhe and Tappel (20) . Enzyme activities were determined by the initial rate of release of phosphorous (21) from appropriate substrates at 37°C and expressed as micromoles of phosphorous released per milligram of protein per hour. Cytochrome c oxidase (EC 1.9.3.1) was measured by the method of Straus (22) and expressed as micrograms of amine hydrochloride formed per milligram protein per minute. Protein was measured by the method of Lowry et al. (23) .
Cholesterol and cholesterol esters were extracted by addition of 20 times sample volume of chloroform-methanol (2:1) as previously described (9) . After evaporation of the chloroform extracts under nitrogen, samples were brought up into 2-propanol and the mass of cholesterol and cholesterol esters were determined using the enzymatic fluorometric assay as described by Heider and Boyett (24) . Cholesterol esters were calculated as the difference between total mass of cholesterol (after hydrolysis with microbial cholesterol esterase) and free cholesterol (no hydrolysis). All values were obtained from a standard curve using authentic free and esterified cholesterol. Repeat determinations of a representative sample were within 5% for both free and esterified cholesterol.
Binding assay. Bile acid binding to liver homogenate and surface membrane fractions were measured in an incubation media that contained 66 mM monosodium/disodium phosphate buffer, pH 6.0, and [14CJcholic acid, as previously described (13 Greater infusion rates oftaurocholate decreased both bile flow and bile acid secretion, and failed to raise maximum hepatic excretory capacity (Tm).' Taurocholate Tm was estimated from the mean of the two highest consecutive 15-min biliary bile acid outputs in each animal.
Bile salt independent bile flow (BSIBF) determttitnatiotn. BSIBF is assumed to be that volume of bile that is theoretically secreted in the absence of bile salt secretion. It was determined indirectly for each group of animals by extrapolating the calculated linear regression of bile flow vs. bile salt secretion to zero bile salt secretion. Although the linear assumption of this line (27) and its total independence from bile salt excretion have been questioned (28) , currently it is a reasonable method to estimate this component of bile flow. Values of slope, y-intercept (BSIBF) and correlation coefficient were calculated using all the experimental values of bile flow and bile salt excretion obtained for each different group of rats.
Mathematical and statistical analysis. Specific cholic acid binding constants, apparent maximal binding capacity and dissociation constant (Kd), were determnined from the plot of cholic acid binding vs. free cholic acid concentrations, as previously described (13) . Best-fit lines and apparenit conlstants were estimated by a nonlinear least squares regression program (29) on a CDC series 6400 computer (Control Data Corp., Minneapolis, Minn.). It has previously been demonstrated by Scatchard analysis that both conjugated and free cholic acid binding at equilibrium best fits a single class ' Abbreviations used in this paper: BSIBF, bile salt independent bile flow; Tm, maximum hepatic excretory capacity. of binding sites that do not demonstrate cooperative interactions (13) .
Variances of best-fit lines were compared by an F test. Significance of differences among estimated parameters was determined by a two-sample t test or a Z score (30) . P values c 0.05 were considered significant.
RESULTS
Effect of ethintyl estradiol treatmtienit on1 wceight, liver surface memtibrante enizyme activities, anid proteint recovertj. As previously shown, the average weight gain of ethinyl estradiol-treated rats (24.5+± 0.5%) compared to corn oil-injected controls (13.5+2.9%, P < 0.05) was significantly decreased, while liver size relative to body weight (4.1±0.2 vs. 5.2±0.2%, P < 0.001) was increased (31) . However, ethinyl estradiol administration did not change liver surface membrane protein recovery (0.25±0.02 vs. 0.28±+ 0.01 mg protein/g liver).
Enzymatic activities from control and ethinyl estradiol-treated rats of liver homogenate and the surface membrane fraction are shown in Table I . Marker enzymes of both the canalicular (Mg++-ATPase and alkaline phosphatase) and sinusoidal (Na+-K+-ATPase) surface membranes show equal enrichment of activities in surface membrane fractions from control and treated rats without apparent preferential purification of either canalicular or sinusoidal membranes. Ethinvl estradiol administration apparently did not alter the smnall degree of intracellular organelle contamiiination in the surface membrane fraction. Compared to control animals, administration of ethinyl estradiol significantly decreased hepatic Na+-K+-ATPase and 5'-nucleotidase and increased alkaline phosphatase and Mg++-ATPase in the surface membrane as well as the homogenate (Table I) .
Bile acid binidinig to liver suirface memtibranie fractiotn.
We have previously shown that [14C]eholic acid specifically binds in a saturable and reversible mannier to liver surface memnbrane fractions (13) . Since in vitro binding kinetic characteristics are similar to those for bile acid transport (7, 13) and since a parallel decrease in transport and the number of bile acid binding sites are observed after cycloheximide administration, it has been proposed that the bile acid receptor represents the putative bile acid carrier (13, 25 administered phenobarbital, a drug also known to increase Na+-K+-ATPase activity (8, 16) to examine whether restoration of normal transport function may be possibly related to changes in sodium pump activity. Phenobarbital administered simultaneously with ethinyl estradiol restored basal bile flow, BSIBF, and Na+-K+-ATPase activity to values not significantly different from control (Table III) . In contrast, although phenobarbital administration restored Na+-K+-ATPase activity to control values, bile acid Tm was still significantly reduced (70% of control value, P < 0.01). When administered in the absence of ethinyl estradiol, phenobarbital increased Na+-K+-ATPase activity and BSIBF but did not alter the maximum hepatic transport of taurocholate (Table III) . The values for bile flow and the activity of Na+-K+-ATPase of rats treated with both phenobarbital and ethinyl estradiol are significantly less than those found for rats treated with phenobarbital alone (Table III) . However, maximal activity was obtained by adding Triton WR-1339 directly to the surface membrane fractions of rats treated with phenobarbital and ethinyl estradiol (Fig. 1) . Thus, the activity of Na+-K+-ATPase increased in a manner related to the amount of Triton WR-1339 added, reaching a value similar to that observed with phenobarbital administration alone. In contrast, Triton WR-1339 did not alter the activity of Na+-K+-ATPase when added to surface membranes from rats treated only with phenobarbital ( Fig. 1) . It has been previously shown that Triton WR-1339 causes a similar stimulation of Na+-K+-ATPase when added to surface membranes from rats treated with ethinyl estradiol alone (9) . Thus, surface membranes from rats treated with ethinyl estradiol with and without phenobarbital possess latent a. 
Effect ofethiinyl estradiol, Triton WR-1339, and pheiobarbital otl hepatic surface membrane lipid co mtposition. To examine whether the inability of phenobarbital to restore reduced bile acid Tm in ethinyl estradiol-treated rats was due to its failure to correct the abnormal hepatic surface membrane lipid composition, the changes in cholesterol and phospholipid were examined in surface membrane fractions from treated and control animals (Fig. 2) . As previously shown for partially purified membrane fractions (9) 4 P < 0.05. § 125,utg/ml Triton WR-1339 added to enzyme before assay, which has a final vol of 2 ml. Partially purified surface membrane fractions were prepared from untreated and ethinyl estradiol(5 mg/kg body wt)-treated rats (29) . Enzyme assays were performed as described in Methods. The results are presented as the mean±SEM of in vivo (n = 9) and in vitro (n = 3) experiments.
values, whether given to the whole animal (in vivo) or added directly to the test tube (in vitro). In contrast, addition of phenobarbital in vitro did not change enzyme activity (data not shown).
Effect of cyclohexiinide on hepatic Na+-K+-ATPase activity, basal bile flotv, and bile salt Tmiz. Cycloheximide, a potent inhibitor of protein synthesis (31) was administered to untreated and ethinyl estradiol-treated rats to determine whether reversal of decreased Na+-K+-ATPase activity, BSIBF, and bile salt Tm after Triton WR-1339 administration to ethinyl estradiol-treated rats is dependent on de novo protein synthesis. Ethinyl estradiol treatment significantly reduced Na+-K+-ATPase activity (54%), BSIBF (67%), and bile salt Tm (56%), whereas Triton WR-1339 returned these parameters to control levels (Table V) . Cycloheximide administration did not prevent Triton WR-1339 reversal of either Na+-K+-ATPase activity or BSIBF in the ethinyl estradiol-treated rat, although the dose employed (150 ug/100 g body wt) has previously been shown to inhibit protein synthesis and decrease bile acid Tm, as well as prevent phenobarbital induction of Na+-K+-ATPase and bile flow (16, 25) .
Neither Na+-K+-ATPase activity nor BSIBF were significantly altered after cycloheximide administration. In contrast, inhibition of protein synthesis reduced bile salt Tm in both untreated and ethinyl estradiol-treated rats to 65 and 59%, respectively.
Triton WR-1339 administration to rats treated with ethinyl estradiol and cycloheximide restores bile salt Tm to levels similar to that found for its control (cycloheximide administration alone; 89%, P = NS). These studies suggest that correction ofbile salt transport with Triton WR-1339 in ethinyl estradiol-treated animals, like that for Na+-K+-ATPase activity and bile flow, does not require protein synthesis.
DISCUSSION
The biochemical events and morphological components involved in the bile secretory process are poorly understood. One requirement to study biliary transport mechanisms is the ability to alter this complex process in a controlled manner. In this sense ethinyl estradiol administration has been shown to predictably reduce BSIBF, and the maximum capacity to excrete organic anions (32) . In addition, this diffuse alteration in canalicular membrane transport is not associated with morphological changes in hepatocyte ultrastructure (33, 34) and thus serves as an excellent model to understand hepatic transport processes.
The transcellular movement of substances in polar epithelial cells requires asymmetry of the membrane transport elements (35) . In this regard, transport of bile acids across the contraluminal membrane (sinusoidal surface) is a carrier-mediated process requiring sodium; whereas, although poorly defined, the rate-limiting luminal (canalicular) carrier-mediated excretory step is probably independent of sodium (36) . The sodium gradient is maintained by Na+-K+-ATPase, whose function can be considered the biochemical equivalent of the sodium pump (37) . Additionally, Na+-K+-ATPase is a transmembrane enzyme whose function is very sensitive to its lipid environment (38) . Thus, its activity is a measure of both the driving forces for the sodium potential difference as well as a probe of the luminal surface membrane structure. In hepatocytes Mg++-ATPase, whose activity is also lipid sensitive (38) , is located on the luminal surface (39) , and thus also provides a convenient in vitro measurement of canalicular membrane structure. Bile acid transport in the hepatocyte may be altered at at least three possible levels. Firstly, the carrier or its affinity for bile acids may be modified at either the sinusoidal or the canalicular membrane surfaces; secondly, at the level of the driving forces, which are derived from the electrochemical potential difference of sodium across the contraluminal surface; and lastly, by changes in the membrane lipid environment through restriction of lateral mobility and/or conformational changes in the carrier.
Estrogen administration is known to alter many hepatic functions (32, 40, 41) and thus it is necessary to quantitate each of the possible steps in bile acid translocation to determine the mechanism(s) of decreased bile acid excretion in ethinyl estradiol-induced bile secretory failure. Previous studies suggested that decreased basal bile flow and Na+-K+-ATPase activity results from decreased surface membrane lipid fluidity (9) . Evidence is presented in this study that changes in the lipid composition of the surface membrane may be indirectly involved in decreased bile acid transport.
This was suggested by the observation that similar to our previous study demonstrating restoration to normal of basal bile flow, reduced bile acid Tm in ethinyl estradiol-treated animals was returned to conitrol values 16 h after Triton WVR-1339 administration.
To examine the possible membrane steps involved in the pathogenesis of ethinyl estradiol-induced cholestasis and its reversal with Triton WR-1339, liver surface membrane fractions were prepared. Anatomically, the surface memnbrane of the liver parenchymal cell is a composite of three functionally different regions, which are a single physical entity (42) . However, it has proven difficult to successfully isolate these coImlponents into fractions free of significant cross contamination from intracellular organelles or other surface membrane regions. While it is not possible to determine the relative enrichment of sinusoidal vs. canalicular membrane regions because both Mg++-ATPase and alkaline phosphatase have intracellular isoenzymes (43) , the marked enrichmiient of Na+-K+-ATPase activity suggests this final membrane fraction-may at the very least contain equal proportions of sinusoidal and canalicular membrane elements. Furthermore, the surface membrane fractions are relatively free of intraReversal of Ethitnyl Estradiol-itndtuced Cholestasis cellular membranes, as judged by intracellular marker enzymes.
As previously shown (8, 16, 31) , administration of ethinyl estradiol is associated with decreased activities of Na+-K+-ATPase and 5'-nucleotidase and increased activities of Mg++-ATPase and alkaline phosphatase. The unaltered relative enrichment of membrane enzymes and recovery of membrane protein through purification of the surface membrane fraction from ethinyl estradiol-treated rats strongly suggests these enzyme changes are not due to alterations in the recovery of membrane fractions. This conclusion is strengthened by the findings that similar enzyme activity alterations are observed in the homogenate. Furthermore (25) .
Transport of bile acids across membranes as with other ligands initially involves their recognition by "carrier" proteins followed by translocation. Measurement of specific binding sites allows in vitro quantitation of this initial step independent of the final interaction with the entire process. Thus, the observation that ethinyl estradiol treatment does not alter the initial recognition step for bile acids suggests that reduced maximum transport capacity is due to abnormalities in translocation which may be mediated by alterations in the driving forces for active transport (contraluminal) or through changes in the membrane lipid environment (luminal and/or contraluminal).
It is generally believed that the rate-limiting step for bile acid transport is luminal excretion, but it is possible that in ethinyl estradiol treatment, reduced bile acid Tm is secondary to a reduced sodium-dependent uptake process, since its administration reduces hepatic sodium pump activity to 50% of control. Therefore, we attempted to increase Na+-K+-ATPase activity to determine if this would also correct bile acid Tm.
Na+-K+-ATPase activity is restored to 107% of control with phenobarbital. In contrast, despite normal bile flow and Na+-K+-ATPase activity, bile acid Tm, is not significantly improved. This finding is consistent with a previous study by Gumucio and co-workers (5) .
The present study confirms the striking elevation in membrane cholesterol esters in a "purified" but mixed surface membrane fraction (9) , however, we did not detect an increased free cholesterol concentration in this study. In other studies we (9) and others (44) (9, 44) . The lipid composition of the surface membrane is complex and it is possible that the changes in the physical structure of surface membranes obtained from ethinyl estradiol-treated rats may be the result of alterations in more than a single lipid component. It is not possible in the present study to determine whether the change in the surface membrane structure is located in a specific surface membrane domain or the change is generalized. However, the observations that:
(a) the activities of both Mg++-ATPase (luminal) and Na+-K+-ATPase (contraluminal) are changed with ethinyl estradiol treatment, (b) that both enzyme activities are restored to control values by in vivo Triton WR-1339 administration; and especially (c) that similar reversal of both abnormal enzyme activities with addition of Triton WR-1339 in vitro, all strongly support the suggestion that the alteration exists in both surface membrane regions.
In contrast to its failure to induce bile acid Tm, phenobarbital induces Na+-K+-ATPase activity in normal rat liver (8, 16) ; and restored reduced activity of ethinyl estradiol-treated rats to control values. However, phenobarbital administration to ethinyl estradiol treated rats does not increase enzyme activity or bile flow to values obtained with phenobarbital alone (Table III). Since phenobarbital induces the number of Na+-K+-ATPase enzyme units in the normal rat (16), these observations suggested the possibility that similar to ethinyl estradiol administration alone the enzyme units are present but unable to function at optimal rates. This hypothesis is strongly supported by activation of latent Na+-K+-ATPase activity in vitro with Triton WR-1339 in the ethinyl estradiol plus phenobarbitaltreated animals to values similar to those found in liver surface imemiibrane fractions from phenobarbital alonetreated rats.
Although cycloheximide has previously been shown to block phenobarbital induction of Na+-K+-ATPase (16), it did not prevent Triton WR-1339 reversal of reduced activity in ethinyl estradiol-treated animals, further suggesting that altered lipid composition is primarily responsible for reduced sodium pump activity. Similarly, protein inhibition does not inhibit restoration of bile acid transport to the level seen with cycloheximide alone.
Previous studies show that ethinyl estradiol increases hepatic cholesterol ester concentrations by activating microsomal cholesterol acyl-CoA transferase (45) . Triton WR-1339 was found to inactivate this enzyme when administered in vivo or when added directly to microsomal fractions obtained from ethinyl estradiol-treated rats (45) . Triton WR-1339 apparently reverses abnormal bile acid transport as well as Na+-K+-ATPase activity and bile flow through mechanisms independent of de nioro protein synthesis. However, the specific mechanism(s) responsible for reversal with Triton WR-1339 is not clear. At least two possibilities exist. First, the concentration of hepatic cholesterol esters is reduced by Triton WR-1339. This may be due either to inhibition of the ethinyl estradiol activation of microsomal cholesterol acyl-CoA transferase, the rate-limiting step for cholesterol esterification (45) ; or possibly Triton WR-1339 may activate lysosomal cholesterol ester hydrolysis. These potential changes in cholesterol ester turnover may be responsible for restoration of normal membrane lipid composition and structure, and thus functional activity. Secondly, Triton WR-1339 may insert directly into the lipid bilayer (46) 
